- Rank in Search Criteria: 2021
World Rank (Aug-2026): 5,432
World Rank (Jan-05-2024): 5,432
World Rank (Jul-30-2023): 5432
World Rank (Jan-2022): 5,432
Headquarters Country: USA Annual Revenue in USD: 117 Million USD
Annual Operating Income in USD: -271 Million USD
Annual Net Income in USD: -291 Million USD
Annual Results for Period ending: For year ending December-2019Company Profile: Portola Pharmaceuticals is a Biotechnology company. It is having more than 380 employees and has offices around the globe and serves patients in more than 50 countries. The company has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome (aHUS) as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder. The headquarters is in USA.
Alexion acquired Portola Pharmaceuticals for 1.41 billion USD.
- Rank in Search Criteria: 2022
World Rank (Aug-2026): 5,432
Market Cap (Aug-2026): 2.634 Billion USD
World Rank (Jan-05-2024): 9,334
Market Cap (Jan-05-2024): 0.87 Billion USD
World Rank (Jul-30-2023): 9662
Market Cap (Jul-30-2023): 0.84 Billion USD
World Rank (Jan-2022): 9,868
Market Cap (Jan-2022): 0.92 Billion USDHeadquarters Country: USA Annual Revenue in USD: 1,134 Million USD
Annual Operating Income in USD: 87 Million USD
Annual Net Income in USD: 33 Million USD
Annual Results for Period ending: For year ending December-2025Employee Count: 700
Employee Count as of Date: As on 2022
Company Profile: Rush Street Interactive is a developing, supplying and operating regulated Online Gaming company. The headquarters is in USA.
Facts About Company: Rush Street Interactive Annual Total Revenue for year ending Dec-2022 was 592 million USD and and Net loss for year ending Dec-2022 was -38 million USD.
Rush Street Interactive Annual Total Revenue for year ending Dec-2021 was 488 million USD and and Net loss for year ending Dec-2021 was -19 million USD.
As on 2022, Rush Street Interactive has 700 employees.
- Rank in Search Criteria: 2023
World Rank (Aug-2026): 5,434
Market Cap (Aug-2026): 2.633 Billion USD
World Rank (Jan-05-2024): 6,023
Market Cap (Jan-05-2024): 1.82 Billion USD
World Rank (Jul-30-2023): 5782
Market Cap (Jul-30-2023): 1.98 Billion USD
World Rank (Jan-2022): 9,999
Market Cap (Jan-2022): 0.90 Billion USDHeadquarters Country: USA Annual Revenue in USD: 1,780 Million USD
Annual Operating Income in USD: -560 Million USD
Annual Net Income in USD: -494 Million USD
Annual Results for Period ending: For year ending December-2025Employee Count: 443
Employee Count as of Date: As on 2021
Company Profile: Talos Energy is a Offshore Energy company. It is focused on oil and gas exploration, production and operations across a range of deepwater and shallow water assets in the United States Gulf of Mexico and offshore Mexico. The headquarters is in USA.
- Rank in Search Criteria: 2024
World Rank (Aug-2026): 5,440
Market Cap (Aug-2026): 2.630 Billion USD
World Rank (Jan-05-2024): 22,095
Market Cap (Jan-05-2024): 0.09 Billion USD
World Rank (Jul-30-2023): 20000
Market Cap (Jul-30-2023): 0.14 Billion USD
World Rank (Jan-2022): 21,111
Headquarters Country: USA Annual Operating Income in USD: -49 Million USD
Annual Net Income in USD: -43 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: Trevi Therapeutics is a clinical-stage biopharmaceutical company that is developing the investigational therapy Haduvio™ to treat serious chronic cough conditions by targeting the central and peripheral nervous systems. Headquarters is in USA.
- Rank in Search Criteria: 2025
World Rank (Aug-2026): 5,454
Market Cap (Aug-2026): 2.622 Billion USD
World Rank (Jan-05-2024): 6,231
Market Cap (Jan-05-2024): 1.72 Billion USD
World Rank (Jul-30-2023): 6500
Market Cap (Jul-30-2023): 1.64 Billion USD
Headquarters Country: USA Annual Revenue in USD: 299 Million USD
Annual Operating Income in USD: 60 Million USD
Annual Net Income in USD: 111 Million USD
Annual Results for Period ending: For year ending December-2025
- Rank in Search Criteria: 2026
World Rank (Aug-2026): 5,456
Market Cap (Aug-2026): 2.620 Billion USD
World Rank (Jan-05-2024): 15,954
Market Cap (Jan-05-2024): 0.29 Billion USD
World Rank (Jul-30-2023): 14713
Market Cap (Jul-30-2023): 0.37 Billion USD
World Rank (Jan-2022): 14,686
Market Cap (Jan-2022): 0.41 Billion USDHeadquarters Country: USA Annual Revenue in USD: 225 Million USD
Annual Operating Income in USD: -8 Million USD
Annual Net Income in USD: -16 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: Axogen is a company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The headquarters is in USA.
Facts About Company: Axogen company annual revenue was 138 million USD and annual net loss was -28 million USD as on Dec-2022.
- Rank in Search Criteria: 2027
World Rank (Aug-2026): 5,458
World Rank (Jan-05-2024): 5,458
World Rank (Jul-30-2023): 5458
World Rank (Jan-2022): 5,458
Market Cap (Jan-2022): 2.52 Billion USDHeadquarters Country: USA Annual Net Income in USD: 108 Million USD
Annual Results for Period ending: For year ending December-2020Company Profile: First Midwest Bancorp is a Retail Banking Holding company. It is the 3rd largest independent Illinois headquartered bank, total assets is $20B, assets under management is $11B, total deposits is $15.7B. The company is having more than 100 locations and dedicated consumer, small business, mortgage and ecommerce teams and having more than 55,000 free ATMS, world class mobile banking and four checking account choices to meet needs. The headquarters is in USA.
- Rank in Search Criteria: 2028
World Rank (Aug-2026): 5,459
World Rank (Jan-05-2024): 5,459
World Rank (Jul-30-2023): 5459
World Rank (Jan-2022): 5,459
Employee Count: 620
Employee Count as of Date: As on 2019
Company Profile: Aphria is a Canadian Cannabis company. It has a market capitalization of $1.2 billion as of January 2020. The headquarters is in Canada.
- Rank in Search Criteria: 2029
World Rank (Aug-2026): 5,463
Market Cap (Aug-2026): 2.614 Billion USD
World Rank (Jan-05-2024): 5,555
Market Cap (Jan-05-2024): 2.07 Billion USD
World Rank (Jul-30-2023): 5345
Market Cap (Jul-30-2023): 2.24 Billion USD
World Rank (Jan-2022): 5,280
Market Cap (Jan-2022): 2.66 Billion USDHeadquarters Country: USA Annual Revenue in USD: -192 Million USD
Annual Operating Income in USD: -196 Million USD
Annual Net Income in USD: -196 Million USD
Annual Results for Period ending: Dec-2022 ending yearEmployee Count: 354
Employee Count as of Date: As on December 2021
Company Profile: COHEN & STEERS INFRASTRUCTURE FUND is a closed-end equity fund launched by Cohen & Steers, Inc. The fund is managed by Cohen & Steers Capital Management, Inc. It invests in public equity markets of the United States. The fund invests primarily in value stocks of infrastructure companies across all market capitalizations.
It was formerly known as Cohen & Steers Select Utility Fund, Inc. Cohen & Steers Infrastructure Fund, Inc. was formed on January 8, 2004 and Headquarters is in USA.
- Rank in Search Criteria: 2030
World Rank (Aug-2026): 5,466
Market Cap (Aug-2026): 2.612 Billion USD
World Rank (Jan-05-2024): 3,549
Market Cap (Jan-05-2024): 3.94 Billion USD
World Rank (Jul-30-2023): 4303
Market Cap (Jul-30-2023): 3.05 Billion USD
World Rank (Jan-2022): 3,267
Market Cap (Jan-2022): 5.03 Billion USDHeadquarters Country: USA Annual Revenue in USD: 673 Million USD
Annual Operating Income in USD: -535 Million USD
Annual Net Income in USD: -575 Million USD
Annual Results for Period ending: For year ending December-2025Employee Count: 1,119
Employee Count as of Date: As on 2021
Company Profile: Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.